Prollenium® Medical Technologies: Advancing Science in Aesthetic Medicine

Who Is Prollenium?

Prollenium Medical Technologies Inc. is a globally recognised manufacturer of medical aesthetics, injectable technologies, and dermal filler innovation. Founded in Canada, Prollenium has built its reputation on a commitment to scientific integrity, advanced manufacturing standards, and clinically validated aesthetic solutions.

Over the past two decades, the company has evolved from a specialised biotechnology manufacturer into a trusted global partner for dermatologists, plastic surgeons, and aesthetic practitioners, supplying high-performance injectable products designed to deliver consistent, predictable, and safe clinical outcomes.

Through continuous investment in research, product development, and global regulatory compliance, Prollenium has established itself as a key contributor to advancing modern aesthetic medicine.

From Canadian Innovation to Global Aesthetic Leadership

Prollenium’s journey began with a clear vision: to develop safe, scientifically engineered injectable technologies that help practitioners achieve natural, reliable aesthetic outcomes.

Operating from its state-of-the-art manufacturing facilities in Canada, the company maintains strict oversight over every stage of production, ensuring:

• Pharmaceutical-grade manufacturing precision
• Rigorous quality assurance protocols
• Compliance with international medical device regulations
• Consistent product performance across global markets

Today, Prollenium products are distributed in more than 70 countries, supporting medical aesthetic practices ranging from specialised dermatology clinics to large multi-disciplinary aesthetic centres.

Science-Driven Innovation in Injectable Technology

Global Reach with Clinical Credibility

With a rapidly expanding international presence, Prollenium has established itself as a global partner in aesthetic medicine. Across multiple international markets, clinicians trust Prollenium solutions for their predictable performance, excellent safety profiles, and reliable clinical outcomes.

This global reach is supported by strong collaborations with distributors, training organisations, and clinical educators, ensuring that practitioners receive both the products and the knowledge required to optimise treatment results.

Commitment to Clinical Research and Education

Prollenium’s dedication to clinical excellence extends beyond product development. The company actively supports the advancement of aesthetic medicine through:

• Ongoing clinical trials and post-market studies
• Peer-reviewed scientific publications
• Collaboration with international key opinion leaders
• Educational programmes and practitioner training

This commitment ensures that practitioners have access to up-to-date clinical data, treatment protocols, and product guidance, enabling them to confidently integrate Prollenium technologies into their practices.

Prollenium Product Portfolio

Prollenium is home to several globally recognised aesthetic brands designed to address a wide range of clinical indications. Together, these product platforms allow practitioners to address multiple treatment indications with predictable, clinically supported solutions.

Whether the goal is facial volumisation, structural contouring, or soft-tissue support, Prollenium provides solutions designed to meet the evolving demands of aesthetic medicine.